EcoDrugPlus

Retinoid X Receptor Alpha

Ensembl ID : ENSBMSG00010021899
Gene Symbol: RXRA
1 Cross references
249 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSBMSG00010010818
Gene Symbol: RXRB
1 Cross references
215 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSBMSG00010007753
Gene Symbol: RXRG
1 Cross references
277 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSBMSG00010004925
Gene Symbol: RPL11
1 Cross references
199 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSBMSG00010021867
Gene Symbol: RPL19
1 Cross references
308 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSBMSG00010003794
Gene Symbol: RPL22
1 Cross references
213 Possible Orthologues:

Ribosomal Protein L23a

Ensembl ID : ENSBMSG00010019988
Gene Symbol: RPL23A
1 Cross references
166 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSBMSG00010011876
Gene Symbol: RPL24
1 Cross references
319 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSBMSG00010013770
Gene Symbol: RPL27
1 Cross references
184 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSBMSG00010010164
Gene Symbol: RPL3
1 Cross references
280 Possible Orthologues:

Ribosomal Protein L31

Ensembl ID : ENSBMSG00010013601
Gene Symbol: RPL31
1 Cross references
178 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSBMSG00010010483
Gene Symbol: RPL32
1 Cross references
101 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).